Fennec Pharmaceuticals Inc.FENCNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank93
3Y CAGR+218.5%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+218.5%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
32.3x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$2.67M-16.2%
2024$3.18M+152.9%
2023$1.26M+1424.4%
2022$82592.00-
2021$0.00-
2020$0.00-
2019$0.00-
2018$0.00-
2017$0.00-
2016$0.00-